Donor graft CMV-serostatus and the risk of arterial and venous thrombotic events in seronegative recipients after non-thoracic solid organ transplantation

Further Publications Infectiology

Temporal trends, risk factors and outcomes of infections due to extended-spectrum β-lactamase producing Enterobacterales in Swiss solid organ transplant recipients between 2012 and 2018

Antimicrob Resist Infect Control

Kohler P, Wolfensberger A, Stampf S, Brönnimann A, Boggian K, van Delden C, Favre M, Hirzel C, Khanna N, Kuster SP, Manuel O, Neofytos D, Ragozzino S, Schreiber PW, Walti L, Mueller NJ, Swiss Transplant Cohort Study.

doi: 10.1186/s13756-021-00918-7

Viral Infections, Non-HIV

COVID-19 in solid organ transplant recipients: dynamics of disease progression and inflammatory markers in ICU and non-ICU admitted patients

Transpl Infect Dis.

Roberts MB, Izzy S, Tahir Z, Al Jarrah A, Fishman JA, El Khoury J

doi: 10.1111/tid.13407.

Bacterial Infections

Risk factors for extended-spectrum beta-lactamase-producing Enterobacterales bloodstream infection among solid organ transplant recipients

Clin Infect Dis.

Anesi JA, Lautenbach E, Tamma PD, Thom KA, Blumberg EA, Alby K, Bilker WB, Werzen A, Tolomeo P, Omorogbe J, Pineles L, Han JH

doi: 10.1093/cid/ciaa190.

Viral Infections, Non-HIV

Heart and Lung Transplants from HCV-Infected Donors to Uninfected Recipients

N Engl J Med.

Woolley AE, Singh SK, Goldberg HJ, Mallidi HR, Givertz MM, Mehra MR, Coppolino A, Kusztos AE, Johnson ME, Chen K, Haddad EA, Fanikos J, Harrington DP, Camp PC, Baden LR, DONATE HCV Trial Team, the DONATE HCV Trial Team

doi: 10.1056/NEJMoa1812406.

Viral Infections, Non-HIV

Clinical Characteristics and Outcomes of COVID-19 in Solid Organ Transplant Recipients: A Case-Control Study

Am J Transplant.

Chaudhry ZS, Williams JD, Vahia A, Fadel R, Acosta TP, Prashar R, Shrivastava P, Khoury N, Corrales JP, Williams C, Nagai S, Abouljoud M, Samaniego-Picota M, Lanfranco OA, Del Busto R, Ramesh MS, Patel A, Alangaden GJ

doi: 10.1111/ajt.16188.

Viral Infections, Non-HIV

Covid-19 in solid organ transplant recipients: A single center experience

Transpl Int.

Hoek RAS, Manintveld OC, Betjes MGH, Hellemons ME, Seghers L, van Kampen JAA, Caliskan K, van de Wetering J, van den Hoogen M, Metselaar HJ, Hesselink DA, Rotterdam Transplant Group.

doi: 10.1111/tri.13662.

Fungal Infections

Invasive Fungal Diseases in Kidney Transplant Recipients: Risk Factors for Mortality

J Clin Med.

Seok H, Huh K, Cho SY, Kang CI, Chung DR, Huh WS, Park JB, Peck KR

doi: 10.3390/jcm9061824.

Viral Infections, Non-HIV

[SARS-CoV-2 infection and solid organ transplantation]

Rev Med Suisse.

Golshayan D, Aubert JD, Hullin R, Moradpour D, Venetz JP, Manuel O, Pascual M

doi: undefined.

HIV / AIDS

Presence of asymptomatic CMV and EBV DNA in blood of persons with HIV starting antiretroviral therapy are associated with non-AIDS clinical events

AIDS.

Gianella S, Moser C, Vitomirov A, McKhann A, Layman L, Scott B, Caballero G, Lada S, Bosch RJ, Hoenigl M, Lurain N, Landay A, Lederman MM, Hunt PW, Smith D

doi: 10.1097/QAD.0000000000002484.

Related content

Temporal trends, risk factors and outcomes of infections due to extended-spectrum β-lactamase producing Enterobacterales in Swiss solid organ transplant recipients between 2012 and 2018

COVID-19 in solid organ transplant recipients: dynamics of disease progression and inflammatory markers in ICU and non-ICU admitted patients

Risk factors for extended-spectrum beta-lactamase-producing Enterobacterales bloodstream infection among solid organ transplant recipients

Heart and Lung Transplants from HCV-Infected Donors to Uninfected Recipients

Clinical Characteristics and Outcomes of COVID-19 in Solid Organ Transplant Recipients: A Case-Control Study

Covid-19 in solid organ transplant recipients: A single center experience

Invasive Fungal Diseases in Kidney Transplant Recipients: Risk Factors for Mortality

[SARS-CoV-2 infection and solid organ transplantation]

Presence of asymptomatic CMV and EBV DNA in blood of persons with HIV starting antiretroviral therapy are associated with non-AIDS clinical events